Clinical trial
Perioperative Cardiovascular Protection Conservative Effects of Esketamine Versus µ-opioid Receptor Agonists in Total Intravenous General Anesthesia: Study Protocol for a Randomized Controlled Pilot Trial
NCT04553536 is registered in ClinicalTrials.gov with Second Hospital of Shanxi Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Perioperative Cardiovascular Protection Conservative Effects of Esketamine Versus µ-opioid Receptor Agonists in Total Intravenous General Anesthesia: Study Protocol for a Randomized Controlled Pilot Trial
- Lead sponsor
- Second Hospital of Shanxi Medical University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 2, 2020
- Completion date
- January 31, 2024
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
opioid analgesic adverse reaction